Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Sep
19
2024
EC Adopts REACH Restriction for PFHxA and Related Substances Bergeson & Campbell, P.C.
Sep
19
2024
Alabama CON Report - September 2024 Bradley Arant Boult Cummings LLP
Sep
19
2024
Landmark Mental Health Parity Final Rule: What Plan Sponsors and Insurers Need to Know McDermott Will & Emery
Sep
19
2024
FDA Release Results of Sampling of Retail Dairy-Free Dark Chocolate and Chocolate-Containing Products for Milk Allergen Keller and Heckman LLP
Sep
19
2024
U.S. Youth Vaping Rates Continue to Show Dramatic Decline Keller and Heckman LLP
Sep
19
2024
DEA Announces Marijuana Rescheduling Hearing Following Elections and the Stakes Are Hugely Consequential Bradley Arant Boult Cummings LLP
Sep
19
2024
This Week in 340B: September 10 – 16, 2024 McDermott Will & Emery
Sep
18
2024
Blank Rome State of the Cannabis Industry Panelist Interview Series: James Daley, Needham Bank Senior Vice President and Director Structured Finance Blank Rome LLP
Sep
18
2024
Health Canada Finalizes Brominated Vegetable Oil Ban Keller and Heckman LLP
Sep
18
2024
California Bans Most Hemp Products and Illuminates Battle Between Hemp and Marijuana Businesses Bradley Arant Boult Cummings LLP
Sep
18
2024
Four Strategies and Five Legal Arguments To Defend Your Company Against EPA’s Benzene Enforcement Initiative Beveridge & Diamond PC
Sep
18
2024
A Study in THC-O: Unpacking the Recent Anderson Case Norris McLaughlin P.A.
Sep
17
2024
Ubrelvy Untitled Letter – A Double Fault for AbbVie? Or Makeup Misread for FDA? Sheppard, Mullin, Richter & Hampton LLP
Sep
17
2024
Will Sustained Pressure on the 340B Program Finally Lead to Much Needed Reform? Mintz
Sep
17
2024
FDA and the Fountain of Youth: Regulatory Hurdles in the Longevity Biotech Community Womble Bond Dickinson (US) LLP
Sep
17
2024
Celanese v. ITC: How the On-Sale Bar Can Turn Sweet Sales into Spoiled Patents Sheppard, Mullin, Richter & Hampton LLP
Sep
17
2024
August 2024 Bounty Hunter Plaintiff Claims Keller and Heckman LLP
Sep
17
2024
Foggy Roads and Auto Accidents: Navigating Liability in Foggy Weather Buckfire Law
Sep
17
2024
The 340B Drug Pricing Program: Top Five Things to Know Foley & Lardner LLP
Sep
17
2024
NCC Requests Extra Time to Comment on FSIS Salmonella Rule Keller and Heckman LLP
Sep
16
2024
U.S. House Of Representatives Passes The BIOSECURE Act During “China Week” Squire Patton Boggs (US) LLP
Sep
16
2024
Understanding Preliminary Injunction: A Review of a Recent Federal Circuit Decision Sheppard, Mullin, Richter & Hampton LLP
Sep
16
2024
Cannabis and Civil Litigation: Has the Cannabis Industry Finally Met Its Most Dangerous Foe? Bradley Arant Boult Cummings LLP
Sep
13
2024
Federal Circuit Says No Timing Requirement to Qualify as A POSITA Foley & Lardner LLP
Sep
13
2024
McDermott+ Check-Up: September 13, 2024 McDermott Will & Emery
Sep
13
2024
USDA and CDFA Declare California Free of Invasive Fruit Flies Keller and Heckman LLP
Sep
13
2024
10 Key Facts About Suboxone Lawsuits: What Patients and Families Need to Know Oberheiden P.C.
Sep
12
2024
IARC Releases Its Priority Evaluation List for 2025-2029 Nelson Mullins
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins